ANTARES PHARMA, INC.·4

May 19, 4:40 PM ET

SADOWSKI PETER L 4

4 · ANTARES PHARMA, INC. · Filed May 19, 2011

Insider Transaction Report

Form 4
Period: 2011-05-17
SADOWSKI PETER L
Senior Vice President
Transactions
  • Award

    Stock Option (right to buy)

    2011-05-17+51,000809,000 total
    Exercise: $1.66Exp: 2021-05-16Common Stock (51,000 underlying)
  • Award

    Common Stock

    2011-05-17+32,000133,221 total
Footnotes (5)
  • [F1]Represents the target number of shares Dr. Sadowski may receive pursuant to the terms of the performance stock unit award made to Dr. Sadowski under the 2008 Equity Compensation Plan if certain performance goals are attained over the three-year period beginning January 1, 2011 and ending December 31, 2013 and Dr. Sadowski continues in employment with the Company through that period.
  • [F2]Not applicable
  • [F3]Represents the total number of shares owned plus all outstanding unearned or unvested shares granted less the number of shares used to fulfill tax withholding obligations when certain shares previously granted became taxable after they were earned or vested.
  • [F4]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
  • [F5]The options vest in equal quarterly installments over three years.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4